9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors

NCT06926998 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Gynecological Malignancies

Interventions

DRUG: 9MW2821+other anticancer therapy

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.